logo
logo

Aadi Bioscience Appoints David Dornan, Ph D As Chief Scientific Officer (CSO)

Feb 20, 2025•7 months ago

Position

Chief Scientific Officer

Company

Aadi Bioscience

David Dornan
Los AngelesTherapeuticsBiotechnologyHealth Care

Description

Aadi Bioscience, Inc (NASDAQ: AADI) has announced the appointment of David Dornan, PhD as the Company's Chief Scientific Officer (CSO). Dr Dornan brings over two decades of experience in oncology drug discovery and development, specifically in antibody-drug conjugates (ADCs) and other targeted cancer therapies.

Company Information

Company

Aadi Bioscience

Location

17383 W Sunset Blvd

Los Angeles, California, United States

About

Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to-treat cancers.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months